Earnings Call · Q3 FY2021·2021-11-08

Q3 21EPS +12.51%·Rev n/aQ2 21EPS +6.09%·Rev n/aQ1 21EPS +5.12%·Rev n/aQ4 20EPS -10.00%·Rev n/a⚠ consensus missing

Alaunos Therapeutics, Inc. TCRT

Alex Lobo — Unknown

Kevin Boyle — Chief Executive Officer

Raffaele Baffa — Chief Medical Officer and Executive Vice President of Research

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TCRT calls or request research access.

More TCRT calls Browse calls Request research access